Danica McKellar’s net worth, biography, fact, career, awards and life story

Net Worth: $6 Million
Date of Birth: Jan 3, 1975 (45 years old)
Gender: Female
Height: 5 ft 3 in (1.6256 m)
Profession: Actor, Screenwriter, Author, Film director, Film Producer, Academician, Advocate
Nationality: United States of America

Danica McKellar net worth: Danica McKellar is an American actress and academic who has a net worth of $6 million. Born in La Jolla, California, Danica McKellar began acting as a child, guest starring on episodes of “The Twilight Zone”. In 1988, she was cast in the role that would make her famous, as Winnie Cooper on “The Wonder Years”. The show ran for six seasons between 1988 and 1993, airing 115 episodes. She then went on to appear in a string of television, television movie, and film projects, including, “Camp Cucamonga”, “Sidekicks”, “Babylon 5”, “Walker, Texas Ranger”, “Sirens”, and “Working”, and she voiced the character of Freida Goren on the animated series, “Static Shock”. Since the early 2000s, she has gone back and forth between guest appearances on television dramas and voice work on various cartoons, including “The West Wing”, “NCIS”, “Jack & Bobby”, “How I Met Your Mother”, “Hack!”, and “The Big Bang Theory”. She graduated from UCLA with a degree in Mathematics, and co-authored a theorem that has been named after her and her fellow mathematicians. She also authored the New York Times bestselling book, “Math Doesn’t Suck: How to Survive Middle-School Math without Losing Your Mind or Breaking a Nail”.

You May Also Like

Viktor Kharitonin’s net worth, biography, fact, career, awards and life story

Viktor Kharitonin Net Worth: Viktor Kharitonin is a Russian businessman who has a net worth of $1 billion. Viktor Kharitonin derives his fortune from the pharmaceutical company Pharmstandard, where he holds a 38% stake. It was in 1993 that Kharitonin started to build his company, which now has a market capitalization of more than $3 billion. At the time, he teamed up with billionaires Roman Abramovich and Evgeny Shvidler to purchase plants from US ICN Pharmaceuticals Russian and thus set the base for Pharmstandard. The trio spent $55 million for the acquisition of the plants. Throughout the 2007 IPO in London, investors estimated the company at $2.2 billion. Arbidol is only one of the well-known drugs that the company is still producing today. Meanwhile, Viktor Kharitonin is building a network of private clinics in Russia.
Read More